Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Not Confirmed
Not Confirmed
03-05 January, 2025
Not Confirmed
Not Confirmed
07-09 January, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
Industry Trade Show
Not Confirmed
07-09 January, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-s-landmark-approvals-of-bms-schizo-med-madrigal-s-mash-drug-us-16-5-bn-catalent-buyout-make-it-to-top-10-news-of-2024
18 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/18/2998800/0/en/ENA-Respiratory-Announces-Peer-Reviewed-Publication-of-First-Time-in-Humans-and-Influenza-Virus-Challenge-Studies-with-the-Intranasal-Innate-Immunomodulator-INNA-051.html
05 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/05/2941066/0/en/ENA-Respiratory-Announces-Extension-of-U-S-Department-of-Defense-Funding-for-Novel-Prophylactic-Antiviral.html
27 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/27/2935974/0/en/ENA-Respiratory-Progresses-Phase-Ib-Study-of-its-Dry-Powder-Formulation-of-Intranasal-Innate-Immunomodulator-INNA-051.html
10 May 2024
// PHARMABIZ
08 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/08/2877495/0/en/ENA-Respiratory-Receives-USPTO-Notice-of-Allowance-for-Key-Patent-Covering-INNA-051-a-First-in-Class-Antiviral-Innate-Immunomodulator.html
29 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/29/2870969/0/en/ENA-Respiratory-Announces-FDA-IND-Clearance-for-its-Prophylactic-Intranasal-INNA-051-a-First-in-Class-Antiviral-Innate-Immunomodulator.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?